BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data

Reuters

Mar 17

BRIEF-<a href="https://laohu8.com/S/PLSE">Pulse Biosciences</a> Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data

March 17 (Reuters) - Pulse Biosciences Inc PLSE.O:

PULSE BIOSCIENCES ANNOUNCES STRATEGIC ALIGNMENT TO ACCELERATE CARDIAC CATHETER PROGRAM FOLLOWING EXCEPTIONAL LONG-TERM AFIB CLINICAL DATA

Source text: ID:nBw7n96HQa

Further company coverage: PLSE.O

((((Reuters.Briefs@thomsonreuters.com;));))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2620216544"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620216544\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620216544?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-17 19:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620216544","market":"fut","top_or_hot":-1,"title":"BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/PLSE\">Pulse Biosciences</a> Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data</title></head><body><p><span>March 17 (Reuters)</span><span> - </span>Pulse Biosciences Inc <span>PLSE.O</span>:</p><ul><li><p>PULSE BIOSCIENCES ANNOUNCES STRATEGIC ALIGNMENT TO ACCELERATE CARDIAC CATHETER PROGRAM FOLLOWING EXCEPTIONAL LONG-TERM AFIB CLINICAL DATA</p></li></ul><p>Source text: <span>ID:nBw7n96HQa</span></p><p>Further company coverage: <span>PLSE.O</span></p><p> ((((Reuters.Briefs@thomsonreuters.com;));))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-17 19:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/PLSE\">Pulse Biosciences</a> Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data</title></head><body><p><span>March 17 (Reuters)</span><span> - </span>Pulse Biosciences Inc <span>PLSE.O</span>:</p><ul><li><p>PULSE BIOSCIENCES ANNOUNCES STRATEGIC ALIGNMENT TO ACCELERATE CARDIAC CATHETER PROGRAM FOLLOWING EXCEPTIONAL LONG-TERM AFIB CLINICAL DATA</p></li></ul><p>Source text: <span>ID:nBw7n96HQa</span></p><p>Further company coverage: <span>PLSE.O</span></p><p> ((((Reuters.Briefs@thomsonreuters.com;));))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PLSE","symbol_name":"Pulse Biosciences, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nFWN4040ZV:1","article_id":"2620216544","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620216544","pubTimestamp":1773748436,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical DataMarch 17 (Reuters) - Pulse Biosciences Inc PLSE.O:PULSE B","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PLSE":"Pulse Biosciences, Inc.","BK4082":"医疗保健设备"},"translate_title":"BRIEF-Pulse Biosciences宣布战略调整，以在获得出色的长期Afib临床数据后加速心脏导管项目","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PLSE":0.9},"content_text":"BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical DataMarch 17 (Reuters) - Pulse Biosciences Inc PLSE.O:PULSE BIOSCIENCES ANNOUNCES STRATEGIC ALIGNMENT TO ACCELERATE CARDIAC CATHETER PROGRAM FOLLOWING EXCEPTIONAL LONG-TERM AFIB CLINICAL DATASource text: ID:nBw7n96HQaFurther company coverage: PLSE.O ((((Reuters.Briefs@thomsonreuters.com;));))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}